Fluorescence Immunoassay (FIA)
Chemiluminescence Immunoassay (CLIA)
Rapid Test (Colloidal gold)
Quality Control
Chest Pain Center
Stroke Center
Trauma Center
Critical Maternal Care Center
Critical Children and Neonatal Care Center
Center for Reproductive Medicine
Hierarchical diagnosis and treatment
Hospital-wide solution
Product Content
undefined
News Content
Performance Evaluation Report of Guangdong Weishi Bio-new Generation of Hypersensitive Cardiac Troponin I(hs-cTnI)
隐藏域元素占位
2023.01~2023.03 Solid Waste Pollution Prevention and Control Information Disclosure
2022.01~2022.12 Solid Waste Pollution Prevention and Control Information Disclosure
Statement
Together, set sail-Guangdong only real biological new corporate promotional film officially released!
"Only" innovation, win the future! Guangdong Weishi biological new products unveiled in 2022 Germany MEDICA medical exhibition
More than 50% of Chinese adults have diabetes or are in the pre-disease stage. See here for diagnostic criteria.
Solid waste pollution prevention and control information disclosure in 2022 (third quarter)
Set sail, create a better future! Guangdong Weishi Bio Brings New Products to CACLP 2022
World Heart Day | professional know "heart", science and technology to protect the "heart"!